The Directory of Open Access Journals
DOAJ Logotype
Open
Global
Trusted
Main actions
Support
Institutions and libraries
Publishers
Institutional and library supporters
Apply
Application form
Guide to applying
The DOAJ Seal
Transparency & best practice
Publisher information
Licensing & copyright
Search
Menu
Secondary actions
Search
Journals
Articles
Documentation
API
OAI-PMH
Widgets
Public data dump
OpenURL
XML
Metadata help
Preservation
About
About DOAJ
DOAJ at 20
DOAJ team
Ambassadors
Advisory Board & Council
Editorial Policy Advisory Group
Volunteers
News
Support
Institutions and libraries
Publishers
Institutional and library supporters
Apply
Application form
Guide to applying
The DOAJ Seal
Transparency & best practice
Publisher information
Licensing & copyright
Login
Login
Quick search
Close
×
Journals
Articles
Search by keywords:
In the field:
In all fields
Title
ISSN
Subject
Publisher
Country of publisher
Search
Frontiers in Oncology
(Sep 2024)
Editorial: Advances in the treatment of hormonal receptor positive (HR+) breast cancer
Wala Ben Kridis,
Zheng Wang,
Deniz Can Guven,
Arunasalam Dharmarajan
Affiliations
Wala Ben Kridis
Habib Bourguiba University Hospital, University of Sfax, Sfax, Tunisia
Zheng Wang
Ruijin Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China
Deniz Can Guven
Cancer Institute, Hacettepe University, Ankara, Türkiye
Arunasalam Dharmarajan
Medical Centre, Sri Ramachandra Institute of Higher Education and Research, Chennai, India
DOI
https://doi.org/10.3389/fonc.2024.1449566
Journal volume & issue
Vol. 14
Abstract
Read online
No abstracts available.
Keywords
breast cancer
CDK 4/6 inhibitors
PIK3CA
genetics
aromatase inhibiters
toxicity
WeChat QR code
Close